ARCHIVES

FDA Approves Votrient For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

Researchers Uncover Tumors Sensitive to Chemotherapy

January 25, 2013

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981

Colorectal Screening Rates Lower In Safety Net System

September 25, 2009

Breast Cancer Patients Track Symptoms With Digital Device

September 25, 2009

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

H. Lee Moffitt Cancer Designated A Comprehensive Cancer Center By NCI.

May 4, 2001